Equities

BioArctic AB

BioArctic AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)189.60
  • Today's Change4.20 / 2.27%
  • Shares traded276.46k
  • 1 Year change-19.66%
  • Beta0.0768
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue61622823
OPERATING EXPENSES
Cost of revenue total513325
Selling, general and admin. expenses, total20011672
Depreciation/amortization181513
Unusual expense(income)------
Other operating expenses, total827353
Total operating expense363246163
Operating income253(17)(140)
Other, net(0.05)(0.19)0.00
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes276(11)(141)
Provision for income taxes470.01(21)
Net income after taxes229(11)(120)
Minority interest------
Net income before extra. Items229(11)(120)
Total extraordinary items------
Net income229(11)(120)
Inc.avail. to common excl. extra. Items229(11)(120)
Inc.avail. to common incl. extra. Items229(11)(120)
EPS RECONCILIATION
Basic/primary weighted average shares888688
Basic/primary eps excl. extra items2.60(0.13)(1.36)
Basic/primary eps incl. extra items2.60(0.13)(1.36)
Dilution adjustment------
Diluted weighted average shares888688
Diluted eps excl. extra items2.59(0.13)(1.36)
Diluted eps incl. extra items2.59(0.13)(1.36)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock0----
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.330.560.84
SUPPLEMENTAL INCOME
Depreciation, supplemental181514
Total special items------
NORMALISED INCOME
Normalized income before taxes276(11)(141)
Effect of special items on income taxes------
Income tax excluding impact of special items470.01(21)
Normalized income after tax229(11)(120)
Normalized income avail. to common229(11)(120)
Basic normalized EPS2.60(0.13)(1.36)
Diluted normalized EPS2.59(0.13)(1.36)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.